Advertisement

Cytotechnology

, Volume 44, Issue 1–2, pp 77–91 | Cite as

Assessment of Stem Cell Markers During Long-Term Culture of Mouse Embryonic Stem Cells

  • A. Berrill
  • H.L. Tan
  • S.C. Wuang
  • W.J. Fong
  • Andre B.H. Choo
  • Steve K.W. Oh
Article

Abstract

Embryonic stem (ES) cells have been in the fore front of scientific literature lately as having the potential for regeneration of many tissue types. Two important issues that need to be addressed are the culture conditions for maintaining ES cells and the accuracy of ES cell markers in monitoring the undifferentiated state. Leukaemia inhibitory factor (LIF) is routinely used to sustain mouse ES cells (mES) in a pluripotent fashion. In this paper, we assessed three markers during long-term maintenance of ES cells with various concentrations of LIF to see if decreasing concentration would lead to changes in marker expressions and growth behavior. Common markers of pluripotency such as alkaline phosphatase enzyme activity (ALP), surface staining for stage specific embryonic antigen 1 (SSEA-1), Oct-4 transcription factor, cell doubling time, as well as visual observations of cell morphology were analyzed during long-term maintenance of mES cells with LIF concentrations ranging from 0 to 500 pM. The morphology of the cells at LIF concentrations of 0 25 pM changed from being tight clusters to more flattened shapes while cells in 50–500 pM retained the clustered shape but growth rates remained essentially identical at between 10 and 16 h. ES cells at all concentrations of LIF continued expressing ALP, SSEA-1 and Oct-4 markers over a period of 6 weeks, which indicate that mES cells are capable of either producing autocrine LIF or are able to proliferate at very low levels of LIF. Pluripotency markers such as Oct-4 and SSEA-1 are only moderately reduced after 5–6 weeks. Oct-4 mRNA expression levels were partially diminished in LIF free conditions only at weeks 5 and 6 compared to controls with LIF at 500 pM. Changes in morphology of cells by visual observation seemed to be a faster indication of the onset of differentiation in mES cells, although other reliable means also include decreased levels of Oct-4, SSEA-1 and ALP markers. It is preferable to maintain long-term cultures of mES cells above 50 pM of LIF to have a more homogenous, stable population of pluripotent cells.

Alkaline phosphatase Leukaemia inhibitory factor SSEA-1 Oct-4 Pluripotency Stem cell culture 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Burdon T., Smith A. and Savatier P. 2002. Signaling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12: 432–438.Google Scholar
  2. Evans M.J. and Kaufman M.H. 1981. Establishment in culture of pluripotent cells from mouse embryos. Nature 292: 154–156.Google Scholar
  3. Hahnel A.C., Rappolee D.A., Millan J.L., Manes T., Ziome C.A., Theodosiou N.G., Werb Z., Pedersen R. and Schultz G.A. 1990. Two alkaline phosphatase genes are expressed during early development in the mouse embryo. Development 110: 555–564.Google Scholar
  4. Heinrich P.C., Behrmann I., Mü ller-Newen G., Schaper F. and Graeve L. 1998. Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem. J. 334: 297–314.Google Scholar
  5. Ling V. and Neben S. 1997. In vitro differentiation of embryonic stem cells: immunophenotypic analysis of cultured embryoid bodies. J. Cell Physiol. 171: 104–115.Google Scholar
  6. Livak K.J. and Schmittgen T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) method. Methods 25: 402–408.Google Scholar
  7. Martin G.R. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinomas stem cells. Proc. Natl. Acad. Sci. USA 78: 7634–7638.Google Scholar
  8. Murray P. and Edgar D. 2001. The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor. Differentiation 68: 227–234.Google Scholar
  9. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Schö ler H. and Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct 4. Cell 95: 379–391.Google Scholar
  10. Niwa H., Miyazaki J. and Smith A.G. 2000. Quantitative expression of Oct3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet 24: 372–376.Google Scholar
  11. Oka M., Tagoku K., Russell T.L., Nakano Y., Hamazaki T., Meyer E.M., Yokota T. and Terada N. 2002. CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol. Biol. Cell 4: 1274–1281.Google Scholar
  12. Pesce M. and Schö ler H.R. 2001. Oct-4: Gatekeeper in the beginnings of mammalian development. Stem Cells 19: 271–278.Google Scholar
  13. Rathjen P.D., Toth S., Willis A., Heath J.K. and Smith A.G. 1990. Differentiation inhibiting activity is produced in matrix associated and diffusible forms that are generated by alternate promoter usage. Cell 62: 1105–1114.Google Scholar
  14. Schö ler H.R. 1991. Octamania: the POU factors in murine development. Trends Genet. 7: 323–329.Google Scholar
  15. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stall M. and Rogers D. 1988. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336: 688–690.Google Scholar
  16. Solter D. and Knowles B.B. 1978. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA 75: 5565–5569.Google Scholar
  17. Viswanathan S., Benatar T., Rose-John S., Lauffenburger D.A. and Zandstra P.W. 2002. Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6. Stem Cells 20: 119–138.Google Scholar
  18. Williams M.A., Gross S.K., Evans J.E. and McCluer R.H. 1988a. Glycolipid stage-specific embryonic antigens (SSEA-1) in kidneys of male and female C57BL/6J and beige adult mice. J. Lipid Res. 29: 1613–1619.Google Scholar
  19. Williams R.L., Hilton D.J., Pease S., Willson T.A., Stewart C.L., Gearing D.P., Wagner E.F., Metcalf D., Nicola N.A. and Gough N.M. 1988b. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684–687.Google Scholar
  20. Yin Y., Lim Y.K., Salto-Tellez M., Ng S.C., Lin C.-S. and Lim S.K. 2002. AFP+, ESC derived cells engraft and differentiate into hepatocytes in vivo. Stem Cells 20: 338–346.Google Scholar
  21. Yoshida K., Chambers I., Nichols J., Smith A., Saito M., Yasukawa K., Shoyab M., Taga T. and Kishimoto T. 1994. Maintenance of the pluripotent phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech. Dev. 45: 163–171.Google Scholar
  22. Zandstra P.W., Le H.V., Daley G.Q., Griffith L.G. and Lauffenburger D.A. 2000. Leukaemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol. Bioeng. 69: 607–617.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • A. Berrill
  • H.L. Tan
  • S.C. Wuang
  • W.J. Fong
  • Andre B.H. Choo
  • Steve K.W. Oh

There are no affiliations available

Personalised recommendations